FDA's approval of new mRNA vaccine does not necessarily signal the government's embrace of the technology, experts say

The U.S. Food and Drug Administration approved an mRNA-based vaccine for influenza. Live Science asked experts what that means for the future of mRNA vaccines in the U.S.